Stefan Oelrich is a member of the Board of Management of Bayer AG and President of its Pharmaceuticals Division, a position he has held since November 2018. Prior to joining the company, he was on the Executive Committee of Sanofi, leading its global Diabetes & Cardiovascular business. During his seven-year tenure, he was also at the helm of Sanofi Germany, Switzerland and Austria, as well as the Diabetes and Cardiovascular business unit in Europe. From 1989 to 2011, Mr. Oelrich held various leadership positions in the health care business of Bayer AG with extensive international experience spanning Latin America (Argentina, Uruguay), Europe (France, Belgium) and the United States. Mr. Oelrich is a member of the Supervisory Board of the university hospital Charité, member of the Supervisory Board of the Berlin Institute of Health and member of the Board of the American Chamber of Commerce in Germany.
Content by this speaker
Further Activities to have a look at